Connect with us

Featured

Stock Price Update: Premier Health Group (OTC: PHGRF) (CSE: PHGI) Seizing Opportunity; Rapid Growth Ahead?

Joe Samuel

Published

on

In the stock market, investors have been cautious following the massive volatility we’ve seen this quarter.  This can make it very difficult to navigate the waters of the stock market. But like we said just a few weeks ago, you need to be able to connect the right dots to find real opportunity.

This month StockPrice has brought a new company to everyone’s attention: Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI). We’ve put together a full report together that highlights how Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could have the same “early potential” as some of the biggest breakouts the small-cap space has seen this year.

There’s a VERY GOOD REASON to pay attention right now:

While everyone is still trying to figure out the “latest trend” in the stock market, big funds are quietly doing something that isn’t getting mass media coverage right now.


Funds Are Redirecting Cash Into Healthcare Stocks


What are they doing? Well, it just so happens that this month Bank of America surveyed[1] 225 fund managers with $641 billion in assets under management, who said the most “crowded trade” is in mainstream tech stocks. Investors are the least optimistic on mainstream tech stocks since the depths of the financial crisis and are instead directing attention to another corner of the market: healthcare.

The survey found that global investors rate health stocks their No. 1 overweight. And in November, they have been selling tech stocks to pile into stock in this sector. As investors make a push to grab hold of the expanding healthcare opportunity, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could be perfect timing this new trend that the majority of funds, like the ones surveyed, are paying close attention to right now.


Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) Takes Aim At Big Growth


On October 31 we published the article, “Ever Hear Of Connecting The Dots? Consider This Your Heads Up.” We wanted to make sure everyone understood the opportunities that this small cap market is presenting right now and emphasize the fact that you don’t need to be Apple Inc. or Amazon to deliver real gains to investors.

Thus far Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has begun to see much more market activity this month. This company is brand new to the North American public markets & with the series of recent announcements, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could be slated for a strong period of growth in the very near term.

This quarter Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) announced their selection of Reliq Health Technologies Inc. as its exclusive technology partner. Reliq is “a healthcare technology company that specializes in developing innovative software as a service solution for the $30 billion community care market.”

Premier Health (OTC: PHGRF) (CSE: PHGI) will look to Reliq to further HealthVue’s telemedicine system by incorporating their technology platform to power the HealthVue patient app.


Latest News Could Open HUGE Doors ForPremier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)


If you haven’t been paying close attention to our updates, consider this your opportunity to get caught up because the company has been strongly focused on growth. Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) announced two key updates that could bring that “very near term potential” directly into the spotlight.

marijuana pharmacy

First, Premier announced that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019. Following this, Premier announced that it will enter the Cannabis clinic space by a series of acquisitions, partnerships and/or launching a new Canada-based chain in the first half of 2019.

Before we get too far into it…we’re less than two months away from 2019 and Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is flat out saying that they will be looking to engage with 2 multibillion-dollar industries within the first half of 2019.

We talk about connecting the dots. Showing you how timing could play a role is just one piece of the pie. Let’s also consider what the marketplace in Canada could offer specifically to Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI).

1. The Canadian retail pharmacy market is estimated to be $44 billion (Source: IBISWorld). It is expected the industry sector will continue to allow for favorable economics for pharmacy operators as baby boomer’s demand increases for prescriptions and operators to expand the scope of practice to include preventative services.

2. The Canadian medical cannabis clinic market is estimated to be worth approximately $2.35 billion by 2025.

If these two facts weren’t enough, there is also a MAJOR Cross Over in Canada that connects medical cannabis & retail pharmacies. For some reason, news outlets aren’t paying attention to it right now either.

The crossover: Canadian pharmacies are fully behind medical marijuana too! Shoppers, Lovell Drugs and PharmaChoice have all signed supply deals with leading cannabis producers in Canada. Their pending entry into the medical cannabis market comes as the number of registered MMJ patients is soaring.

Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could have an ideal business model in progress that would vertically integrate cannabis as another growth opportunity; it could be only months away as the company states the plan being for the first half of 2019.


This Could Be Just The Beginning


Why say this? Statistics from Premier Health’s subsidiary, HealthVue, show that roughly 15% of Canadians aged 12 and older don’t have a primary care physician. On top of this, nearly two-thirds of seniors are also unable to get a same-or next-day appointment. This contributes to about 7 in 10 Canadians avoiding seeing a doctor when they are sick.

Though cannabis is very exciting, it represents just one part of what could become an even larger market opportunity for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI). HealthVue has an ecosystem of over 100,000 active patients, and according to the company, they also have plans to “rapidly increase that number both domestically and internationally.” Unlike other telehealth companies, HealthVue also has four clinics in British Columbia with plans to expand to the rest of Canada via its telemedicine model.

The benefit for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is that it can tap into the existing payment structure that Canada offers. Unlike the US, the telemedicine visits are already covered by the provincial health insurance plans in several provinces, so there is no cost to the patient to access this service. HealthVue expects to make the first version of the app available to their patients in Q4-18.

health care technology

Besides cannabis, big pharmacies and healthcare systems are beginning to see the light when it comes to telemedicine. The resulting success could open big doors for the global market and for companies like Premier Health (OTC: PHGRF) (CSE: PHGI) to get a piece of the pie. Just look at some of the leading pharmacies aiming telemedicine:

1. Rite Aid (RAD), the third largest pharmacy in America, has begun searching for a useful telehealth technology for its customers both in store and virtually.

2. Walgreens (WBA) is connecting with more than a dozen healthcare providers, working to launch a new virtual marketplace used to join its online customers with store- and community-based services.

3. CVS has even begun to explore opportunities in telehealth with early ventures. The CVS Pharmacy app leverages back-end technology of telemedicine to offer the service to its subscribers.

The “Big Three” in the pharmacy industry are looking for the advantage and telemedicine could give them just that. The move follows the trends of a new consumer and the tendency to shift care outside of hospitals and clinics to where patients already are. Could Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) be next to get a nod for its telehealth platform?


Market Opportunity Indicates Rapid Growth


Telemedicine is also becoming a more significant part of health care treatment in rural areas, and more hospitals are embracing video consultations.  Reports[2] from firms like Polaris Market Research & Consulting found that the global telehealth market was valued at $3.1 Billion in 2017 and is anticipated to reach $16.7 Billion by 2025 growing at a CAGR of 23.5%.

After observing this kind of rapid expansion within a short period, it stands to reason that not only is healthcare in for a change but also calls for more attention to be placed on companies getting involved early on.

The opportunity to see rapid market adoption in Canada could offer companies within this industry an even greater opportunity. With the healthcare arena, especially in Canda, presenting numerous opportunities for growth Premier Health Group (OTC: PHGRF) (CSE: PHGI) could have a first mover advantage and the upper hand.

Click Here For Full Report On Premier Health Group (OTC: PHGRF) (CSE: PHGI)

stock price

Endnotes:

[1] Bank of America Survey: http://rsch.baml.com/r?q=ui5Blsf2sZL82JuY5OSH6g&e=cburroughs%40businessinsider.com&h=0tU5cQ&ps=true

[2] Polaris Market Research: https://www.polarismarketresearch.com/press-releases/telehealth-market/

Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full disclaimer.

Continue Reading
Click to comment

Featured

Stock Price Mid-Day Update

Jon Phillip

Published

on

What a way to start the week.  The markets are green right now and even ahead of all of the expected financial meetings this week, sentiment is high.  That’s true too for the companies we talked about this morning. So let’s dive in and get everyone caught up to speed.

ParcelPal Technology Inc. (PKG.CN) (PTNYF) Jumps On Integration News

ParcelPal Technology Inc. (PKG.CN) (PTNYF) has been on the move for most of the month and the recent jump comes on the heels of this penny stock announcing integration on the Shopify platform. If you’re wondering, this is the same Shopify that trades publicly at OVER $300 a share!

Now the deal was first scooped by Benzinga and was later confirmed when ParcelPal formally announced the deal later in morning. Businesses of any kind, notably cannabis merchants will be able to integrate their Shopify eCommerce store nearly instantly to ParcelPal’s ecosystem.

These merchants will enable their customers to tap into ParcelPal’s network and have their products delivered in an hour or less. ParcelPal has begun this process with Choom and Kiaro. You can read more about the ParcelPal/Shopify News Here. Since June 3, ParcelPal is up by more than 35% and we, for one, will continue to bring more updates as we find them.

GT Biopharma, Inc. (GTBP) Consolidation Could Lead To More Excitement

GT Biopharma, Inc. (GTBP) continues to pick up the pace.  Since we initiated coverage on the company, we’ve watch GTBP climb as much as 30% and as of today, it’s still up by roughly 12.5% in just over a week. We have seen a bit of consolidation to start this week but that could open the door to more excitement in June. The big focus for GTBP onlookers has been on its immunotherapy portfolio.

The bottom line here is that big money is pouring into cancer-focused companies specifically. The fact that as we write this, Pfizer is in the middle of an $11 billion dollar deal to buy a cancer therapy company should be even more proof of this focus.

To date, GT Biopharma has completed one dose escalation Phase I-II expansion clinical trial, and one fixed dose Phase I-II expansion clinical trial, which collectively enrolled a combined 43 patients. On the surface, the Phase I-II expansion clinical trial demonstrated greater than 50% of Evaluable patients receiving 60 mg/kg dose had a positive clinical response.

Two patients exhibited a Complete Remission with one patient currently disease-free at 50 months post-treatment. Additionally, five patients exhibited Stable Disease, cancers that are neither increasing nor decreasing in severity, with the longest response lasting 12 months post-treatment. In addition to this, the company’s therapy has also shown that it could target HIV infected cells in the University of Minnesota’s preclinical testing. Not only that but in specific tests, data showed that HIV-infected targets that express the HIV envelope on their surface could be eliminated. We’ve put together a full report on GTBP so click here for more info.

Liberty Defense Holdings, Ltd. (SCAN.V) Surges On German Deal

We brought this back to the attention of our members earlier last week and since then things have been quite exciting to say the least. Here’s why: Liberty Defense was trading at CAD$0.69 and today we’ve witnessed a big boom to highs of $0.85 after making another big MOU announcement.  What was the news? Liberty Defense (SCAN.V) will be collaborating with FC Bayern München to beta test HEXWAVE. You can read the whole PR here.

This is what Bill Riker, CEO of Liberty Defense, said about this deal, “The reception to our HEXWAVE product has been fantastic and we are excited about working alongside FC Bayern Munich, a team that is a household name in both Europe and North America. Our ability to deploy in both indoor and outdoor settings, with covert and overt applications, sets us apart and has also been driving increasing interest from the market.”

stock price today
Disclaimer: MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to June 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to July 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares.

Pursuant to an agreement between MIDAM VENTURES, LLC and GT Biopharma, Midam was hired for a period from 06/07/2019 – 7/07/2019 to publicly disseminate information about GT Biopharma including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of GT Biopharma in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 04/15/2018 – 5/15/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter now extended through June 21, 2019. We were paid $350,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

 Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Monday Morning Update – June 17, 2019

Joe Samuel

Published

on

stock price newsletter

ParcelPal (PKG.CN) (PTNYF) & Shopify (SHOP) Integration Opening Big Doors For Cannabis In Canada

Originally scooped by Benzinga (see: Scoop: Shopify And ParcelPal To Integrate For Cannabis Delivery In Canada), ParcelPal has formally announced that it will be integrating with Shopify to offer cannabis products to customers of Shopify shops. This will be available in Vancouver, Calgary, and Saskatchewan. Customers ordering from Shopify stores in these areas will be able to receive cannabis at their own homes.

Click For Full Coverage


Liberty Defense (SCAN.V) to Collaborate with FC Bayern München to Beta Test HEXWAVE

VANCOUVER and MÜNCHEN, Germany, June 17, 2019 /PRNewswire/ – Liberty Defense Holdings, Ltd. (“Liberty”) (TSXV: SCAN; FRANKFURT: LD2), a leader in security and weapons detection solutions, is pleased to announce that the company has signed a Memorandum of Understanding (“MOU”) with the German soccer team, FCBayern München (“FC Bayern”), a German football club based in Munich, Bavaria (“Bayern”) to beta test HEXWAVE.

Click For Full Release


Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks

If you’ve ever invested in the stock market or traded a single share, chances are you’ve familiarized yourself with the “hot markets”. These are the ones that consistently see enormous volatility and gains that most only dream of.

See For Yourself


Disclaimer: MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to June 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to July 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares.

Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 04/15/2018 – 5/15/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter now extended through June 21, 2019. We were paid $350,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Featured

Liberty Defense (SCAN.V) to Collaborate with FC Bayern München to Beta Test HEXWAVE

Joe Samuel

Published

on

stock market news june

VANCOUVER and MÜNCHEN, Germany, June 17, 2019 /PRNewswire/ – Liberty Defense Holdings, Ltd. (“Liberty”) (TSXV: SCAN; FRANKFURT: LD2), a leader in security and weapons detection solutions, is pleased to announce that the company has signed a Memorandum of Understanding (“MOU”) with the German soccer team, FCBayern München (“FC Bayern”), a German football club based in Munich, Bavaria (“Bayern”) to beta test HEXWAVE.

Allianz Arena, the home of FC Bayern, has a 75,000-seating capacity and is the second largest arena in Germany.

HEXWAVE uses low-power, radar imaging and artificial intelligence primarily to detect and identify weapons, while enabling a layered defense strategy for a venue, meaning the ability to detect threats at the perimeter of the property without obstructing the movement of large groups of people.

“The reception to our HEXWAVE product has been fantastic and we are excited about working alongside FC Bayern Munich, a team that is a household name in both Europe and North America,” said Bill Riker, CEO of Liberty Defense. “Our ability to deploy in both indoor and outdoor settings, with covert and overt applications, sets us apart and has also been driving increasing interest from the market.”

Product testing in actual facilities, in partnership with organizations such as FC Bayern, are a crucial part of the product development process for HEXWAVE to ensure that the product is aligned to market requirements. Testing in Europe will likely take place following the initial testing in North America.

Beta testing involves testing HEXWAVE in a live environment with the initial Alpha testing to occur at Liberty’s Center of Excellence laboratory in Atlanta, Georgia.

Oliver Meßthaler, head of security FC Bayern München said, “We look forward to working with Liberty Defense to assess the capabilities of the HEXWAVE product.”

“We are pleased to have the opportunity to work with FC Bayern and have them sign on to become the first early adopter in Europe of this advanced technology,” added Riker.

The weapons detections systems market size is expected to reach over US$7.5 billion by 2025, up from US$4.9 billion today, with public venues such as stadiums comprising 20% of the market. Europe alone is expected to make up 24% of this global market, according to a 2018 report from Homeland Security Research Corp.

On Behalf of Liberty Defense
Bill Riker
CEO & Director

About Liberty Defense
Liberty provides security solutions for concealed weapon detection in high volume foot traffic areas and has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement, for patents related to active 3D radar imaging technology that are packaged into the HEXWAVE product. The system is designed to provide discrete, modular and scalable protection to provide layered, stand-off detection capability. This is intended to provide a means to proactively counter evolving urban threats. The sensors with active 3D radar imaging and Artificial Intelligence (AI)-enhanced automatic detection are designed to detect metallic and non-metallic firearms, knives, explosives and other threats. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions. Learn more: LibertyDefense.com

About FC Bayern München
Football-Club Bayern München AG., commonly known as FC Bayern München, FCB, Bayern Munich, or FC Bayern, is a German sports club based in Munich, Bavaria (Bayern). It is best known for its professional football team, which plays in the Bundesliga, the top tier of the German football league system, and is the most successful club in German football history, having won a record 29 national titles and 19 national cups. Allianz Arena has a 75,000 seating capacity and is the second largest arena in Germany.

FORWARD-LOOKING STATEMENTS

When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. The forward-looking statements and information in this press release include, amongst others, information relating to the expectation for development of HEXWAVE and future Beta testing. Such statements and information reflect the current view of Liberty. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the development of HEXWAVE and future Beta testing. These fluctuations may adversely affect the price of the Liberty’s securities, regardless of its operating performance. There are a number of important factors that could cause Liberty’s actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; and general market and industry conditions. The parties undertake no obligation to comment on analyses, expectations or statements made by third parties in respect of their securities or their respective financial or operating results (as applicable).

Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com